Evidence map›Paper›PMID 37322153›Full record

ArticleNature chemical biology2023

Direct enzymatic sequencing of 5-methylcytosine at single-base resolution.

Tong Wang, Johanna M Fowler, Laura Liu, Christian E Loo, Meiqi Luo, Emily K Schutsky, Kiara N Berríos, Jamie E DeNizio, Ashley Dvorak, Nick Downey and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Tong WangGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-4208-5578
Johanna M FowlerDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-2248-2947
Laura LiuDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-3120-149X
Christian E LooGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-7060-3558
Meiqi LuoDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-8063-0250
Emily K SchutskyGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-4885-6353
Kiara N BerríosGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-0684-5413
Jamie E DeNizioGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
Ashley DvorakIntegrated DNA Technologies, Inc., Coralville, IA, USA.
Nick DowneyIntegrated DNA Technologies, Inc., Coralville, IA, USA.
Saira MontermosoGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-8494-9162
Bianca Y PingulGraduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
MacLean NasrallahDepartment of Pathology, University of Pennsylvania, Philadelphia, PA, USA.
Walraj S GosalCambridge Epigenetix, Saffron Walden, United Kingdom.
Hao WuDepartment of Genetics, University of Pennsylvania, Philadelphia, PA, USA.
Rahul M KohliDepartment of Medicine, University of Pennsylvania, Philadelphia, PA, USA. rkohli@pennmedicine.upenn.edu.ORCID 0000-0002-7689-5678
University of Pennsylvania · USIntegrated DNA Technologies (United States) · US

Funding

Ultra low-input epigenetic sequencing with combined enzymatic and long-read technologiesR01HG010646 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Gang Fang, Rahul Manu Kohli · 2019 to 2026
$3.9M
Advancing Epigenetic Sequencing Through Solid-Phase Enzymatic ApproachesF31HG012892 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI LOO, CHRISTIAN ETHAN · 2023 to 2024
$95k
NHGRI NIH HHS F31 HG012892NHGRI NIH HHS HG-012892NHGRI NIH HHS R01 HG010646NHGRI NIH HHS R01-HG10646NIGMS NIH HHS T32-GM07729
6 · The paper itself

Abstract

5-methylcytosine (5mC) is the most important DNA modification in mammalian genomes. The ideal method for 5mC localization would be both nondestructive of DNA and direct, without requiring inference based on detection of unmodified cytosines. Here we present direct methylation sequencing (DM-Seq), a bisulfite-free method for profiling 5mC at single-base resolution using nanogram quantities of DNA. DM-Seq employs two key DNA-modifying enzymes: a neomorphic DNA methyltransferase and a DNA deaminase capable of precise discrimination between cytosine modification states. Coupling these activities with deaminase-resistant adapters enables accurate detection of only 5mC via a C-to-T transition in sequencing. By comparison, we uncover a PCR-related underdetection bias with the hybrid enzymatic-chemical TET-assisted pyridine borane sequencing approach. Importantly, we show that DM-Seq, unlike bisulfite sequencing, unmasks prognostically important CpGs in a clinical tumor sample by not confounding 5mC with 5-hydroxymethylcytosine. DM-Seq thus offers an all-enzymatic, nondestructive, faithful and direct method for the reading of 5mC alone.

Indexed as

5-MethylcytosineDNA MethylationAnimalsCytosineDNAMammalsSequence Analysis, DNA5-MethylcytosineCytosineDNA

Identifiers

PMID37322153
PMCPMC10763687
OpenAlexW4380791912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.